Compounds > 4-aminopyridine
Page last updated: 2024-10-21

4-aminopyridine and Breathlessness

4-aminopyridine has been researched along with Breathlessness in 1 studies

Research Excerpts

ExcerptRelevanceReference
"4-Aminopyridine (4-AP) is a recent treatment indicated to improve walking in patient with multiple sclerosis."7.91Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine. ( Chabot, F; Chaouat, A; Gomez, E; Guillaumot, A; Petitpain, N; Ribeiro Baptista, B; Valentin, S; Yelehé-Okouma, M, 2019)
"4-Aminopyridine (4-AP) is a recent treatment indicated to improve walking in patient with multiple sclerosis."3.91Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine. ( Chabot, F; Chaouat, A; Gomez, E; Guillaumot, A; Petitpain, N; Ribeiro Baptista, B; Valentin, S; Yelehé-Okouma, M, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ribeiro Baptista, B1
Petitpain, N1
Gomez, E1
Yelehé-Okouma, M1
Valentin, S1
Guillaumot, A1
Chabot, F1
Chaouat, A1

Other Studies

1 other study available for 4-aminopyridine and Breathlessness

ArticleYear
Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.
    Fundamental & clinical pharmacology, 2019, Volume: 33, Issue:1

    Topics: 4-Aminopyridine; Antihypertensive Agents; Dyspnea; Female; Humans; Hypertension, Pulmonary; Middle A

2019